某年度美國外用止痛藥市場分析報告(ppt 55頁)

某年度美國外用止痛藥市場分析報告內容提要：
Market Overview
Market Overview 一般情況
Major “Non-Natural Product” OTC Brands主要OTC品牌
Direct Natural Product Competitors: 主要天然產品競爭對手
Tiger Balm Case: Early Disappointment, Later Success 虎牌早期不滿意後來較成功的案例
Capsasin Brands Case: Early Success, Later Disappointment 開普莎早期成功，後期不滿意
O24 Case: Failure O24 的失敗案例
ALCiS Case
Conclusion 結論
Market Overview
Market Overview
Major "Non-Natural Product" OTC Brands
Direct Natural Product Competitors:
Tiger Balm Case: Early Disappointment, Later Success
Capsasin Brands Case: Early Success, Later Disappointment
O24 Case: Failure
ALCiS Case
Conclusion
While the overall OTC and RX pain medication market combined is huge…鎮痛藥的處方藥與OTC 整體市場很大
In 2003, the TOTAL U.S OTC and RX market for pain products was $12 billion： 03年120億美元
By some measures, the US pain market alone is larger than the entire Chinese pharmaceutical market in 2003
…the market for topical OTC is only $500 M - $700 M 外用OTC藥5-7億美元
However, sales of OTC topical analgesics are estimated to be only $500 -$700 million
Prescription products, such as opioids and “NSAIDs” such as COX-2 inhibitors constitute most of the market. 口服的解熱鎮痛藥如非甾抗炎藥絕對為主
The market for COX-2’s alone (such as Vioxx and Celebrex) exceeds $5,000,000,000 (RMB 40,000,000,000). 僅環氧化酶2抑製劑藥50億美元

..............................